In the case of drugs, the packaging not only contributes to the marketing mix but also has a significant impact on the qualities, use, and shelf life of the product. The safety of children, the elderly, and medications from damage, germs, the outside environment, and microbes must all be considered in drug packaging. Types of pharmaceutical packaging:
- Packaging
- Aluminium foil
- Vials/Bottles for Injectables
- Boxes
- Board
- Paper Lamini tubes
- Combinations Based on PVC
The packaging used by the pharmaceutical industry varies from drug to medicament and frequently includes three tiers, referred to as primary, secondary, and tertiary packaging.
1. The items that initially surround and support the product, also known as the primary packaging system, include blister packs, prefilled syringes, IV containers, ampoules and vials, prefilled syringes, and other items. Blister packs, prefilled syringes, IV containers, ampoules and vials, prefilled syringes, and other items that actually come into contact with the product or that may have an immediate impact on its shelf life are examples of aluminium foil subcomponents. 1. The primary packaging system consists of the materials that first enclose and support the product, or those package elements.
2. Injection trays, cartons, and boxes are utilised as secondary packaging solutions to group large products together outside of the main container.
3. For bulk handling and shipping, tertiary packaging solutions such barrels, containers, edge guards, etc. are used.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico